Cargando…

Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia

Disease recurrence is the most important obstacle to achieve long-term survival for patients with advanced acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In order to reduce the relapse risk and improve the survival, the strategy of early tapering o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jun, Cai, Yu, Jiang, JieLing, Wan, LiPing, Bai, HaiTao, Zhu, Jun, li, Su, Wang, Chun, Song, Xianmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797220/ https://www.ncbi.nlm.nih.gov/pubmed/29250743 http://dx.doi.org/10.1007/s00277-017-3204-6

Ejemplares similares

Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?
por: Perales, Miguel-Angel, et al.
Publicado: (2020)

Simulation shows that HLA-matched stem cell donors can remain unidentified in donor searches
por: Sauter, Jürgen, et al.
Publicado: (2016)

Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Kadri, Yasmine, et al.
Publicado: (2022)

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
por: O'Leary, Jacqueline G., et al.
Publicado: (2016)

Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
por: Swatler, Julian, et al.
Publicado: (2021)

Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT
por: Poiré, Xavier, et al.
Publicado: (2020)

Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study
por: Ruggeri, Annalisa, et al.
Publicado: (2016)

Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study
por: Yang, Jun, et al.
Publicado: (2018)

Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
por: Hyun, Shin Young, et al.
Publicado: (2020)

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR
por: Bachanova, Veronika, et al.
Publicado: (2014)

Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation
por: Sun, Xi, et al.
Publicado: (2021)

Identification of the immunosuppressive effect of γδ T cells correlated to bone morphogenetic protein 2 in acute myeloid leukemia
por: Liang, Shuang, et al.
Publicado: (2022)

Comparison of Matched Unrelated and Matched Related Donor Myeloablative Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia in First Remission
por: Walter, Roland B., et al.
Publicado: (2010)

Support of Unrelated Stem Cell Donor Searches by Donor Center-Initiated HLA Typing of Potentially Matching Donors
por: Schmidt, Alexander H., et al.
Publicado: (2011)

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
por: Vinson, Amanda Jean, et al.
Publicado: (2018)

Decision analysis for donor selection in stem cell transplantation—HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor
por: Kanda, J, et al.
Publicado: (2014)

Alternative Donor Transplantation for Acute Myeloid Leukemia
por: Bejanyan, Nelli, et al.
Publicado: (2015)

HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age
por: Ambinder, Alexander, et al.
Publicado: (2022)

Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy
por: Cossu, Giulio, et al.
Publicado: (2015)

Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy
por: Cossu, Giulio, et al.
Publicado: (2016)

Ensuring HLA‐matched platelet support requires an ethnic diverse donor population
por: Kreuger, Aukje L., et al.
Publicado: (2020)

A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients
por: Lu, Wenyi, et al.
Publicado: (2022)

On the Poisonous Agents Found in Coloured Tapers
por: Macfarlane, James
Publicado: (1874)

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party
por: Rubio, Marie T., et al.
Publicado: (2016)

High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia
por: Wang, Bichen, et al.
Publicado: (2023)

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
por: Ruggeri, Annalisa, et al.
Publicado: (2018)

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
por: Brissot, Eolia, et al.
Publicado: (2020)

Can PIRCHE-II Matching Outmatch Traditional HLA Matching?
por: Unterrainer, Christian, et al.
Publicado: (2021)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
por: Williams, Louis, et al.
Publicado: (2020)

Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm
por: Rieger, Max J., et al.
Publicado: (2023)

Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants
por: Wang, Hong, et al.
Publicado: (2017)

Novel Agents for Acute Myeloid Leukemia
por: Luppi, Mario, et al.
Publicado: (2018)

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children
por: Park, Meerim, et al.
Publicado: (2011)

The Impact of HLA-C Matching on Donor Identification Rates in a European-Caucasian Population
por: Eberhard, Hans-Peter, et al.
Publicado: (2014)

Time to Move on: HLA Matching Should Be Reconsidered in Modern Deceased Donor Kidney Allocation
por: Gramlick, Madelyn E., et al.
Publicado: (2022)

Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin
por: Narayan, Rupa, et al.
Publicado: (2019)

Brain toxoplasmosis after HLA haploidentical transplantation for acute myeloid leukemia
por: Tsushima, Takafumi, et al.
Publicado: (2022)

Megadose CD34+ Hemopoietic Stem Cell Transplantation for Patients with High Risk Acute Myeloid Leukemia Who Have No HLA Matched Donor: A Pilot Study of a Full Haplotype Mismatch Transplantation
por: Kim, Hee-Je, et al.
Publicado: (2004)

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
por: Brissot, Eolia, et al.
Publicado: (2017)

Clinical Characteristics and Outcome Analysis for HLA Loss Patients Following Partially Mismatched Related Donor Transplantation Using HLA Chimerism for Loss of Heterozygosity Analysis by Next-Generation Sequencing
por: Wang, Andi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3fkdf4155g8scucobemu2sgsd6